169 related articles for article (PubMed ID: 27456700)
1. Evaluation of potential drug- drug interactions among Palestinian hemodialysis patients.
Al-Ramahi R; Raddad AR; Rashed AO; Bsharat A; Abu-Ghazaleh D; Yasin E; Shehab O
BMC Nephrol; 2016 Jul; 17():96. PubMed ID: 27456700
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of drug-drug interactions among patients with chronic kidney disease in a South-Eastern Nigeria tertiary hospital: a retrospective study.
Adibe MO; Ewelum PC; Amorha KC
Pan Afr Med J; 2017; 28():199. PubMed ID: 29610637
[TBL] [Abstract][Full Text] [Related]
7. Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals.
Rabba AK; Abu Hussein AM; Abu Sbeih BK; Nasser SI
Biomed Res Int; 2020; 2020():9634934. PubMed ID: 33029535
[TBL] [Abstract][Full Text] [Related]
8. Assessment of prescribed medications and pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa.
Fasipe OJ; Akhideno PE; Nwaiwu O; Adelosoye AA
Clin Pharmacol; 2017; 9():125-132. PubMed ID: 29123429
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
Straubhaar B; Krähenbühl S; Schlienger RG
Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536
[TBL] [Abstract][Full Text] [Related]
11. [Hypertension in hemodialysis patients in Andalucia].
García Cortés MJ; Ceballos M;
Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of contraindications and prescription of pharmacologic therapies for gout.
Keenan RT; O'Brien WR; Lee KH; Crittenden DB; Fisher MC; Goldfarb DS; Krasnokutsky S; Oh C; Pillinger MH
Am J Med; 2011 Feb; 124(2):155-63. PubMed ID: 21295195
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
[TBL] [Abstract][Full Text] [Related]
14. Relation between number of prescribed medication and outcome in peritoneal dialysis patients.
Szeto CC; Chow KM; Kwan BC; Leung CB; Chung KY; Law MC; Li PK
Clin Nephrol; 2006 Oct; 66(4):256-62. PubMed ID: 17063992
[TBL] [Abstract][Full Text] [Related]
15. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.
Johnell K; Klarin I
Drug Saf; 2007; 30(10):911-8. PubMed ID: 17867728
[TBL] [Abstract][Full Text] [Related]
16. Identifying and Communicating Clinically Meaningful Drug-Drug Interactions.
Nelson SD; LaFleur J; Hunter E; Archer M; Steinvoort C; Maden C; Oderda GM
J Pharm Pract; 2016 Apr; 29(2):110-5. PubMed ID: 25107417
[TBL] [Abstract][Full Text] [Related]
17. The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients.
Rosas-Carrasco O; García-Peña C; Sánchez-García S; Vargas-Alarcón G; Gutiérrez-Robledo LM; Juárez-Cedillo T
Rev Invest Clin; 2011; 63(6):564-73. PubMed ID: 23650669
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of stroke in northern palestine: a 1-year, hospital-based study.
Sweileh WM; Sawalha AF; Al-Aqad SM; Zyoud SH; Al-Jabi SW
J Stroke Cerebrovasc Dis; 2008; 17(6):406-11. PubMed ID: 18984436
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and severity of upper gastrointestinal complications among patients with chronic diseases: a cross-sectional study from Palestine.
Al Ramahi R; Tumeh D
BMC Gastroenterol; 2024 May; 24(1):175. PubMed ID: 38773426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
